Tvardi Therapeutics, Inc.
TVRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001346830
No open-market purchases or sales by Tvardi Therapeutics, Inc. insiders were filed in the last 90 days; 57 institutions reported holding it in 13F filings for Q2 2026, worth $4.24M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Tvardi Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 186
- +1 vs. Q4 2021
- Shares held
- 31.7M
- +1.44M (+4.8%) vs. Q4 2021
- Total value
- $385.5M
- +$16.7M (+4.5%) vs. Q4 2021
- New holders
- 27
- 49 more added
- Sold out
- 26
- 71 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TVRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 57 | $4.24M |
| Q1 2026 | 67 | $8.60M |
| Q4 2025 | 67 | $12.1M |
| Q3 2025 | 73 | $102.2M |
| Q2 2025 | 56 | $44.9M |
| Q1 2025 | 35 | $3.21M |
| Q4 2024 | 45 | $6.59M |
| Q3 2024 | 71 | $4.17M |
| Q2 2024 | 81 | $4.56M |
| Q1 2024 | 101 | $21.5M |
| Q4 2023 | 112 | $18.1M |
| Q3 2023 | 124 | $45.6M |
| Q2 2023 | 138 | $83.3M |
| Q1 2023 | 164 | $166.4M |
| Q4 2022 | 163 | $364.7M |
| Q3 2022 | 167 | $323.6M |
| Q2 2022 | 183 | $317.9M |
| Q1 2022 | 186 | $385.5M |
| Q4 2021 | 186 | $368.9M |
| Q3 2021 | 173 | $457.1M |
| Q2 2021 | 175 | $444.0M |
| Q1 2021 | 172 | $703.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Tvardi Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cutler Group LP | 0 | $0 | 0.00% | −1,330−100.0% | Sold out |
| Cornerstone Advisory, LLC | 0 | $0 | 0.00% | −1,315−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −470−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −239−100.0% | Sold out |
| Horizon Financial Services, LLC | 0 | $0 | 0.00% | −242−100.0% | Sold out |
| Signet Financial Management, LLC | 0 | $0 | 0.00% | −151−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −88−100.0% | Sold out |
| Covington Capital Management | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Wagner Wealth Management, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Harbour Investments, Inc. | – | – | – | – | Not filed |